about
Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in EuropeArboviral and other illnesses in travellers returning from Brazil, June 2013 to May 2016: implications for the 2016 Olympic and Paralympic GamesLong-term kinetics of Zika virus RNA and antibodies in body fluids of a vasectomized traveller returning from Martinique: a case reportA phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adultsSafety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial.Travel-associated infection presenting in Europe (2008-12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation.Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations.Filariasis in travelers presenting to the GeoSentinel Surveillance Network.Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network.Evidence for significant influence of host immunity on changes in differential blood count during malaria.Travel and migration associated infectious diseases morbidity in Europe, 2008.Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008.Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe.Health risks in travelers to South Africa: the GeoSentinel experience and implications for the 2010 FIFA World Cup.Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study populationLocal and International Implications of Schistosomiasis Acquired in Corsica, France.Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011-2012.GeoSentinel surveillance of illness in returned travelers, 2007-2011Hepatitis A and B booster recommendations: implications for travelers.Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network.Acute and potentially life-threatening tropical diseases in western travelers--a GeoSentinel multicenter study, 1996-2011Spectrum of Imported Infectious Diseases: A Comparative Prevalence Study of 16,817 German Travelers and 977 Immigrants from the Tropics and Subtropics.Lymphocytosis and Lymphopenia Induced by Imported Infectious Diseases: A Controlled Cross-Sectional Study of 17,229 Diseased German Travelers Returning from the Tropics and Subtropics.Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006.Travel-associated illness trends and clusters, 2000-2010.Travel-associated diseases, Indian Ocean Islands, 1997-2010.Expert opinion on vaccination of travelers against Japanese encephalitis.Regional variation in travel-related illness acquired in Africa, March 1997-May 2011.Causes of non-malarial fever in Laos: a prospective studyAcute undifferentiated febrile illness in rural Cambodia: a 3-year prospective observational studySafety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.Clostridium difficile infection in returning travellers.Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.Cutaneous leishmaniasis (Leishmania tropica) in a German tourist after travel to Greece.Latitudinal patterns of travel among returned travelers with influenza: results from the GeoSentinel Surveillance Network, 1997-2007.Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network.Health risks in travelers to China: the GeoSentinel experience and implications for the 2008 Beijing Olympics.Spectrum of disease and relation to place of exposure among ill returned travelers.
P50
Q24796344-F3A6BF5F-5B1A-4C3A-ABEF-845847E4FEC7Q25707426-CA88CF68-0079-4DCB-A30E-3C3A62C37E61Q28223073-2D7816DC-E7E2-4CD4-9E13-F109FBA13BA9Q30353708-E5277FF5-68F7-46DA-B833-187535235563Q30368814-55F94E8A-B7DD-4FF9-8C38-D52CF0E32F73Q30369417-3FD190A6-DF03-4158-83BF-ACCFC16868B9Q30410983-92405267-2E95-4AA5-AA6F-C91B53E4F086Q30414633-EA872381-5EF2-4EE3-BF42-10FA7F21AEF9Q30417211-6430C510-FADF-4D0E-BF31-E63873A10243Q33312446-1C90826B-0079-4E57-BFEF-36FAECF9ECA0Q33324017-E0A7EC87-1BFE-4801-A0B2-B557A9329C6FQ33612319-2712DADD-A93B-4317-8DF1-7EF7EA09479EQ33748967-1226FF16-F8E2-43D8-BD04-828D6023824CQ33800678-CCC54DE4-0C98-4BCA-8C70-778CCA46BFD7Q33800754-9803507E-8E34-4254-9E5B-9013AC7B04FFQ33880771-0F407E01-F29E-4D76-9D86-78189595CB4AQ35447516-C4673B67-6FBD-402C-AE49-087030EFF88EQ36121636-9349C974-1432-4E5D-BC99-562593D52B72Q36219206-2C4187EE-CF2E-4D7C-ACBC-6E490A4F4A15Q36239501-4E0A3883-FAFB-4C3F-BF7D-F3FF13ADED9FQ36249100-6BE1C636-EED7-414A-8353-E596D49AA6B6Q36618024-7F088D05-B3CD-4AFD-BCA4-7587EC8E0C92Q36641864-D835140B-2412-4E61-B5A7-B5BEAA24339DQ36776026-06BAA174-3BD2-4B64-9F15-42A6C6CBA01CQ36958565-44AA6787-4CD3-452A-9027-EE9A08644BC2Q37009420-A161A1F3-45A7-4493-9399-B2A4EB63470FQ37021081-22A4E003-E17B-40AA-87A2-3231884C12FCQ37085091-047EB944-C1C7-4F90-A1CE-42C34E0EA583Q37524448-D4F07B63-DD23-4C43-8D94-452E31BBA031Q37664593-301B5EE9-0D4A-4B5F-82BE-F8B9FDA0D0BCQ37701868-6A5EF7EF-6812-423F-A67D-F4AFE6912C72Q37717057-197E075C-287B-4A55-BA90-398E38433421Q38867466-07606C37-098C-4D91-9540-E1CD73979EB7Q38868807-A3BB2C1D-1A48-4910-AA7B-6E2DC5E53F78Q38900076-722380E6-06DB-4017-8630-96397A07F309Q38904823-D8B9F79D-B145-43E5-BB33-A8E8F5297225Q38913228-8771D514-73F2-4501-BF78-AA89A4C89472Q38913240-C3FC1CE9-6D6D-4701-8FE9-5DFBB3DE7EAEQ38963906-EB5CCAA8-10EB-4B2D-8763-21C391050408Q39011352-8906E930-7D6D-4D03-A19A-75C7A0ED09CA
P50
description
onderzoeker
@nl
name
Frank von Sonnenburg
@ast
Frank von Sonnenburg
@en
Frank von Sonnenburg
@es
Frank von Sonnenburg
@nl
Frank von Sonnenburg
@sl
type
label
Frank von Sonnenburg
@ast
Frank von Sonnenburg
@en
Frank von Sonnenburg
@es
Frank von Sonnenburg
@nl
Frank von Sonnenburg
@sl
prefLabel
Frank von Sonnenburg
@ast
Frank von Sonnenburg
@en
Frank von Sonnenburg
@es
Frank von Sonnenburg
@nl
Frank von Sonnenburg
@sl